Preoperative Exposure to Oral First-Generation Cephalosporins and Periprosthetic Joint Infection: A Cautionary Association in the U.S. Population Level
Background While patient-specific risk factors for periprosthetic joint infection (PJI) are well-defined, the impact of recent antibiotic exposure as a marker of infection vulnerability remains unclear. This study evaluated whether recent preoperative exposure to oral first-generation cephalosporins (OFGCs) is associated with increased PJI risk following elective total joint arthroplasty (TJA). Methods We performed a retrospective study using a national database. Exposure was receiving OFGCs for nonmusculoskeletal indications within 1-year preoperatively. Patients undergoing elective primary TJA were propensity-matched 1:1 to unexposed patients (N = 247,207) by age, sex, Charlson Comorbidity Index, obesity, diabetes, and smoking. Outcomes were surgical procedures for PJI and all-cause revision at 90 days and 1-year. Results OFGC exposure was associated with higher PJI incidence at 90 days (1.49% vs 1.10%, OR 1.35, 95% CI 1.29-1.41, P < .0001) and 1-year (2.59% vs 1.89%, OR 1.39, 95% CI 1.34-1.44, P < .0001). Exposed patients had higher rates of PJI-related surgical procedures at 90 days (1.09% vs 0.78%, OR 1.39, 95% CI 1.32-1.46, P < .0001) and 1-year (1.89% vs 1.32%, OR 1.44, 95% CI 1.38-1.51, P < .0001). PJI rates remained higher across infection indications. Neither vancomycin cefazolin prophylaxis nor postoperative EOA mitigated this association. Conclusions Recent OFGC exposure was a marker of increased PJI risk following elective primary TJA, regardless of antibiotic indication. This association may reflect underlying patient or healthcare-related factors rather than a direct antibiotic effect. Future studies should determine whether OFGC exposure not only identifies higher-risk patients but also influences the microbiological and clinical course of PJI. Level of Evidence Level III.
Authors
- Erik N. Hansen (ORCID: https://orcid.org/0000-0003-1038-3335)
- Jessica L Abrolat (ORCID: https://orcid.org/0009-0009-7010-7966)
- Ahmad M. Zedan (ORCID: https://orcid.org/0009-0002-4889-1407)
- Claudio Díaz-Ledezma (ORCID: https://orcid.org/0000-0002-0982-5258)
- Arezo Ebne Ahmadi (ORCID: https://orcid.org/0009-0006-3919-9442)
Institutions
- University of California, San Francisco (US)
- University of California San Francisco Medical Center (US)
Publication Details
- Journal
- Arthroplasty Today
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1016/j.artd.2026.102211
- Primary Topic
- Orthopedic Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00